Texas A&M Football Recruiting

Three Things: Home opener welcomes 100-plus prospects to Kyle Field

As he does every Friday morning, TexAgs' senior recruiting analyst Jason Howell offered up another round of his weekly recruiting thoughts. In this edition of his Three Things, Howell dives into potential commits and offers, big names visiting Kyle Field and more.
By Jason Howell
September 4, 2026
4.7k Views
Discuss
Story Poster
Photo by Will Huffman, TexAgs

1. It’s game weekend. Let’s talk about the commitment possibilities this weekend

  • Over/Under for a new commitment this weekend – 0.5
  • Flipping 2027 ATH Za’Kari Johnson from Florida State is the biggest opportunity. If the Aggies really push, I think it happens.
  • In 2028, I’d put the best odds on Carthage WR JD Edwards‍. The Aggies are high on his list, his brother is on the team, and he has been on the radar since his freshman year.
To continue reading, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Three Things Texas A&M vs. Missouri State Aaron Gregory Ty McCurry Sean Sherman Jayden Thompson Jai'Storm Knight JD Edwards Zyron Forstall Jeremiah Tabor Kaden Henderson Khalen Taylor
Show All
Donald Tabron II Tyler Armstrong CJ Whaley Isaiah Taylor BJ LaFell Jaden Davis Shamar Evans Raiden Johnson Elijah Smith Jay'Maree Bowens Brayden Boults Mac Horton Jax Wilkerson Jayshawn Mitchell Shamar Nichols Damari Woodson Za'Kari Johnson Football Recruiting Texas A&M Missouri State 2026 2027 2028 2029 2030
SPONSORED BY
Hudson Oaks
More Football Recruiting
See All →
Texas A&M Offer Recap - Sept 6-13
By Jason Howell
An update on a weekend visitor committed elsewhere
By Ryan Brauninger
2028 OL Jamarios Canton returned to Kyle Field on Saturday
By Jason Howell
Highlights: Allen beats Southlake Carroll in battle of TXHSFB powers
By Jason Howell
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.